↓ Skip to main content

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

Overview of attention for article published in Journal of Clinical Oncology, May 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Readers on

mendeley
1571 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Published in
Journal of Clinical Oncology, May 2015
DOI 10.1200/jco.2014.58.3377
Pubmed ID
Authors

Robert H I Andtbacka, Howard L Kaufman, Frances Collichio, Thomas Amatruda, Neil Senzer, Jason Chesney, Keith A Delman, Lynn E Spitler, Igor Puzanov, Sanjiv S Agarwala, Mohammed Milhem, Lee Cranmer, Brendan Curti, Karl Lewis, Merrick Ross, Troy Guthrie, Gerald P Linette, Gregory A Daniels, Kevin Harrington, Mark R Middleton, Wilson H Miller, Jonathan S Zager, Yining Ye, Bin Yao, Ai Li, Susan Doleman, Ari VanderWalde, Jennifer Gansert, Robert S Coffin

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 98 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1,571 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 4 <1%
United Kingdom 3 <1%
Germany 3 <1%
Israel 1 <1%
France 1 <1%
Spain 1 <1%
Switzerland 1 <1%
Brazil 1 <1%
Australia 1 <1%
Other 0 0%
Unknown 1555 99%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 229 15%
Student > Ph. D. Student 178 11%
Researcher 178 11%
Student > Master 163 10%
Other 81 5%
Other 225 14%
Unknown 517 33%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 323 21%
Biochemistry, Genetics and Molecular Biology 234 15%
Agricultural and Biological Sciences 146 9%
Immunology and Microbiology 110 7%
Pharmacology, Toxicology and Pharmaceutical Science 63 4%
Other 134 9%
Unknown 561 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 534. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 August 2026.
All research outputs
#58,883
of 34,350,842 outputs
Outputs from Journal of Clinical Oncology
#87
of 32,292 outputs
Outputs of similar age
#443
of 308,390 outputs
Outputs of similar age from Journal of Clinical Oncology
#1
of 459 outputs
Altmetric has tracked 34,350,842 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,292 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 308,390 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 459 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.